Genetic variants in XRRC5 may predict development of venous thrombotic events in myeloma patients on thalidomide

Prerna Tewari*, Elaine Kenny, Anthony Staines, Stephen Chanock, Paul Browne, Mark Lawler

*Corresponding author for this work

Research output: Contribution to journalLetter

7 Citations (Scopus)
Original languageEnglish
Pages (from-to)5691-5692
Number of pages2
JournalBlood
Volume113
Issue number22
DOIs
Publication statusPublished - 28 May 2009

Cite this